Global Health Progress – Collaborating for a sustainable future (flyer)
Related news and resources
Industry perspectives on implementation of Quality Overall Summary-Product Dossier (QOS-PD) and Quality Information Summary (QIS) for innovative medicinal products
In view of a growing complexity of product lifecycle management, industry puts forward perspectives to support the harmonization of regulatory requirements. These are intended to facilitate efficient regulatory review and approval to support timely implementation of changes and product improvements, leading to more resilient supply chains.
Read more
IFPMA welcomes announcement of first three regulatory agencies listed under WHO Listed Authorities Framework
On 2 November, IFPMA and its member associations in South Korea, Singapore and Switzerland have welcomed the appointment of the Korean Ministry of Food and Drug Safety (MFDS) of South Korea, the Health Sciences Authority (HSA) of Singapore, and Swissmedic of Switzerland as the first three Listed Authorities under the WHO Listed Authorities (WLA) framework.
Read moreIFPMA statement on Universal Health Coverage at the 76th session of WHO Regional Committee for South-East Asia
On 2 November in New Delhi, India, IFPMA submitted a statement on Universal Health Coverage (UHC) at the 76th session of WHO Regional Committee for South-East Asia.
Read more